📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years. (2015)

First Author: Musoke P

Attributed to: Paediatric and adolescent infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/qad.0000000000000749

PubMed Identifier: 26193705

Publication URI: http://europepmc.org/abstract/MED/26193705

Type: Journal Article/Review

Volume: 29

Parent Publication: AIDS (London, England)

Issue: 13

ISSN: 0269-9370